Latest News On Vaccines

Latest California Healthline Stories

KHN’s ‘What the Health?’: Dealing With Drug Prices

Medicare officials tentatively plan to restrict the use of a controversial Alzheimer’s drug to only those patients participating in clinical trials, while the Department of Health and Human Services looks into lowering the monthly Medicare Part B premium. Meanwhile, covid confusion still reigns, as the Biden administration moves, belatedly, to make more masks and tests available. Joanne Kenen of Politico and the Johns Hopkins Bloomberg School of Public Health, Sarah Karlin-Smith of the Pink Sheet and Rachel Cohrs of Stat join KHN’s Julie Rovner to discuss these issues and more.

Incidental Cases and Staff Shortages Make Covid’s Next Act Tough for Hospitals

As omicron sweeps the country, many hospitals are dealing with a flood of people hospitalized with covid — including those primarily admitted for other reasons. While often milder cases, so-called incidental covid infections still drain the beleaguered health care workforce and can put them and other patients at higher risk for contracting covid.

KHN’s ‘What the Health?’: Contagion Confusion

It’s 2022 and the covid-19 pandemic is still with us, as are congressional efforts to pass President Joe Biden’s big health and social spending bill. But other issues seem certain to take center stage on this year’s health agenda, including abortion, the state of the health care workforce, and prescription drug prices. Tami Luhby of CNN, Alice Miranda Ollstein of Politico and Mary Ellen McIntire of CQ Roll Call join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews KHN’s Victoria Knight, who reported the latest KHN-NPR “Bill of the Month” episode.